Sangamo BioSciences | DETTE



Debt Changement Date
Alaunos Therapeutics USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amgen USD 57.38B 2.72B 2025-03
Bayer EUR 39.39B 1.31B 2025-03
Biogen USD 6.3B 2M 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.91M 2.91M 2024-12
CSL USD 11.96B 219M 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Grifols EUR 9.23B 626.05M 2024-12
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
J&J USD 52.25B 15.62B 2025-03
Merck USD 34.84B 2.27B 2025-03
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 21.05B 3.14B 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Sangamo BioSciences DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.